# Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement

> **NCT07385742** · NA · COMPLETED · sponsor: **Suez Canal University** · enrollment: 20 (actual)

## Conditions studied

- Temporomandibular Joint Internal Derangement
- Temporomandibular Joint Disorders
- Temporomandibular Disorders (TMD)
- TMJ Pain

## Interventions

- **PROCEDURE:** Injectable Platelet-Rich Fibrin (I-PRF) Injection
- **DRUG:** Botulinum Toxin Type A (BOTOX) Injection

## Key facts

- **NCT ID:** NCT07385742
- **Lead sponsor:** Suez Canal University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-10
- **Primary completion:** 2025-03-11
- **Final completion:** 2025-04-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385742, "Botulinum Toxin Versus Platelet Rich Fibrin for TMJ Internal Derangement". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07385742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*